CRISPR-based Gene Editing Market To Reach $9.14 Billion By 2030

CRISPR-based Gene Editing Market Growth & Trends

The global CRISPR-based gene editing market size is anticipated to reach USD 9.14 billion by 2030 and is projected to grow at a CAGR of 14.73% from 2024 to 2030, according to a report by Grand View Research, Inc. This robust growth trajectory in the market is driven by several key factors, including the rising prevalence of genetic disorders, significant advancements in CRISPR technology, supportive regulatory frameworks, and increasing investments in biotechnology and healthcare research. Together, these elements create a dynamic environment for innovation and development.

Advancements in CRISPR technology have notably fueled market expansion. Researchers have made remarkable progress in developing more precise and efficient CRISPR systems, including CRISPR/Cas9, CRISPR/Cas12, and emerging base editing technologies. These innovations have broadened the scope of potential applications, extending from treating genetic disorders to formulating targeted therapies for various cancers and infectious diseases. The enhanced ability to edit genes with high specificity and minimal off-target effects has captured considerable interest from both pharmaceutical and biotechnology sectors, which are increasingly eager to leverage these groundbreaking technologies for therapeutic development.

Moreover, the growing emphasis on personalized medicine is significantly influencing the demand for CRISPR technologies. As the healthcare landscape shifts toward more individualized treatment approaches, the capability to edit genes with precision enables the creation of therapies tailored to the unique genetic profiles of patients. This paradigm shift in medicine is likely to further accelerate the adoption of CRISPR technologies, as they provide unparalleled opportunities to develop targeted and effective treatments that can dramatically improve patient outcomes.

Supportive regulatory frameworks are fostering a conducive environment for research and commercialization. Regulatory bodies are increasingly recognizing the potential of CRISPR technologies, leading to streamlined approval processes that encourage innovation. Overall, the confluence of these factors positions the market for continued growth and innovation in the coming years, paving the way for revolutionary advancements in healthcare and biotechnology.

 Request a free sample copy or view report summary: CRISPR-based Gene Editing Market Report

CRISPR-based Gene Editing Market Report Highlights

• The products segment, which includes CRISPR kits and reagents, CRISPR libraries, and other related tools, led the market with the largest revenue share of 73.96% in 2023

• Based on application, the biomedical segment led the market with the largest revenue share of 81.83% in 2023 and is also projected to witness at the fastest CAGR of 15.09% during the forecast period. This growth is fueled by several key drivers, including the increasing prevalence of genetic disorders and cancers, alongside significant advancements in CRISPR technology

• Based on end use, the pharmaceutical & biotechnology companies segment led the market with the largest revenue share of 46.31% in 2023

CRISPR-based Gene Editing Market Segmentation

Grand View Research has segmented the global CRISPR-based gene editing market report based on product & service, application, end use, and region:

CRISPR-based Gene Editing Product & Service Outlook (Revenue, USD Million, 2018 - 2030)

• Products

  • CRISPR Kits & Reagents

  • CRISPR Libraries

• Others

• Services

CRISPR-based Gene Editing Application Outlook (Revenue, USD Million, 2018 - 2030)

• Biomedical

  • Therapeutic Development

    • By Indication

      • Genetic Disorders

      • Oncology

      • Ophthalmology

      • Others

    • By Delivery Method

      • Ex Vivo

      • In Vivo

  • Disease Diagnostics

• Agricultural applications

  • Plant Engineering

  • Farm Animals Engineering

  • Others

CRISPR-based Gene Editing End Use Outlook (Revenue, USD Million, 2018 - 2030)

• Pharmaceutical & Biotechnology Companies

• Academic & Research Institutes

• Contract Research Organizations

CRISPR-based Gene Editing Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • UK

  • Germany

  • France

  • Italy

  • Spain

  • Denmark

  • Sweden

  • Norway

• Asia Pacific

  • Japan

  • China

  • India

  • Australia

  • South Korea

  • Thailand

• Latin America

  • Brazil

  • Argentina

• MEA

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

List of Key Players in the CRISPR-based Gene Editing Market

• Revvity, Inc.

• Danaher

• GenScript

• Merck KGaA

• Thermo Fisher Scientific, Inc.

• Tocris Bioscience

• OriGene Technologies, Inc.

• Bio-Rad Laboratories

• Bio-Techne

• New England Biolabs, Inc.